Co-ablation of Trp53 with each of the three genes led to more efficient mammary tumor formation19,23,25,26, and a Trp53 heterozygous background also promoted mammary tumorigenesis in Brca1 CKO mice22,24. This evidence concerns the gene BRCA1 and breast cancer.